Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixekizumab vs placebo in moderate-to-severe genital psoriasis
2015-002628-14Phase 3Completed
- Start
- Feb 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in psoriasis comparing Ixekizumab with Placebo (2 arms). Primary endpoint: Static Physician Global Assessment of Genitalia (sPGA of Genitalia). Started Feb 2016; status: completed.
02
Drugs
ixekizumab
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2015-002628-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002628-14.